Literature DB >> 15040175

Chagas disease.

Carlos M Morel1, Janis Lazdins.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 15040175     DOI： 10.1038/nrmicro735

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN： 1740-1526            Impact factor:   60.633


× No keyword cloud information.
  27 in total

1.  CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

Authors:  Adriano F S Araújo; Bruna C G de Alencar; José Ronnie C Vasconcelos; Meire I Hiyane; Cláudio R F Marinho; Marcus L O Penido; Silvia B Boscardin; Daniel F Hoft; Ricardo T Gazzinelli; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Modeling disease vector occurrence when detection is imperfect: infestation of Amazonian palm trees by triatomine bugs at three spatial scales.

Authors:  Fernando Abad-Franch; Gonçalo Ferraz; Ciro Campos; Francisco S Palomeque; Mario J Grijalva; H Marcelo Aguilar; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

3.  Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the southern United States.

Authors:  Emily L Brown; Dawn M Roellig; Matthew E Gompper; Ryan J Monello; Krista M Wenning; Mourad W Gabriel; Michael J Yabsley
Journal:  Vector Borne Zoonotic Dis       Date:  2009-12-18       Impact factor: 2.133

4.  Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.

Authors:  Galina I Lepesheva; Robert D Ott; Tatiana Y Hargrove; Yuliya Y Kleshchenko; Inge Schuster; W David Nes; George C Hill; Fernando Villalta; Michael R Waterman
Journal:  Chem Biol       Date:  2007-11

5.  Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.

Authors:  Eduardo L V Silveira; Carla Claser; Filipe A B Haolla; Luiz G Zanella; Mauricio M Rodrigues
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

6.  Familial analysis of seropositivity to Trypanosoma cruzi and of clinical forms of Chagas disease.

Authors:  Roseane L Silva-Grecco; Marly A S Balarin; Dalmo Correia; Aluízio Prata; Virmondes Rodrigues
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

7.  NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

Authors:  Hisako Kayama; Ritsuko Koga; Koji Atarashi; Megumi Okuyama; Taishi Kimura; Tak W Mak; Satoshi Uematsu; Shizuo Akira; Hiroshi Takayanagi; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

Review 8.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07

9.  Autochthonous transmission of Trypanosoma cruzi, Louisiana.

Authors:  Patricia L Dorn; Leon Perniciaro; Michael J Yabsley; Dawn M Roellig; Gary Balsamo; James Diaz; Dawn Wesson
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

10.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.